Literature DB >> 28108486

Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection.

Shomyseh Sanjabi1,2, Soyoung A Oh3, Ming O Li3.   

Abstract

Transforming growth factor β (TGF-β) is a pleiotropic cytokine involved in both suppressive and inflammatory immune responses. After 30 years of intense study, we have only begun to elucidate how TGF-β alters immunity under various conditions. Under steady-state conditions, TGF-β regulates thymic T-cell selection and maintains homeostasis of the naïve T-cell pool. TGF-β inhibits cytotoxic T lymphocyte (CTL), Th1-, and Th2-cell differentiation while promoting peripheral (p)Treg-, Th17-, Th9-, and Tfh-cell generation, and T-cell tissue residence in response to immune challenges. Similarly, TGF-β controls the proliferation, survival, activation, and differentiation of B cells, as well as the development and functions of innate cells, including natural killer (NK) cells, macrophages, dendritic cells, and granulocytes. Collectively, TGF-β plays a pivotal role in maintaining peripheral tolerance against self- and innocuous antigens, such as food, commensal bacteria, and fetal alloantigens, and in controlling immune responses to pathogens.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28108486      PMCID: PMC5453394          DOI: 10.1101/cshperspect.a022236

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  373 in total

Review 1.  HIV-1 Tat: immunosuppression via TGF-beta1 induction.

Authors:  D Reinhold; S Wrenger; T Kähne; S Ansorge
Journal:  Immunol Today       Date:  1999-08

2.  Transforming growth factor-beta1 preserves epithelial barrier function: identification of receptors, biochemical intermediates, and cytokine antagonists.

Authors:  S Planchon; C Fiocchi; V Takafuji; J K Roche
Journal:  J Cell Physiol       Date:  1999-10       Impact factor: 6.384

3.  TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells.

Authors:  F Geissmann; P Revy; A Regnault; Y Lepelletier; M Dy; N Brousse; S Amigorena; O Hermine; A Durandy
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

4.  Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter.

Authors:  J Hanai; L F Chen; T Kanno; N Ohtani-Fujita; W Y Kim; W H Guo; T Imamura; Y Ishidou; M Fukuchi; M J Shi; J Stavnezer; M Kawabata; K Miyazono; Y Ito
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

5.  Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice.

Authors:  M P Schön; A Arya; E A Murphy; C M Adams; U G Strauch; W W Agace; J Marsal; J P Donohue; H Her; D R Beier; S Olson; L Lefrancois; M B Brenner; M J Grusby; C M Parker
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

6.  Seminal transforming growth factor-beta in normal and infertile men.

Authors:  B Loras; F Vételé; A El Malki; J Rollet; J C Soufir; M Benahmed
Journal:  Hum Reprod       Date:  1999-06       Impact factor: 6.918

7.  Cytokines (IL-1beta, IL-6, TNF-alpha, TGF-beta1, and TGF-beta2) and prostaglandin E2 in human milk during the first three months postpartum.

Authors:  J S Hawkes; D L Bryan; M J James; R A Gibson
Journal:  Pediatr Res       Date:  1999-08       Impact factor: 3.756

8.  The relationship between defects in lymphocyte production of transforming growth factor-beta1 in systemic lupus erythematosus and disease activity or severity.

Authors:  K Ohtsuka; J D Gray; M M Stimmler; D A Horwitz
Journal:  Lupus       Date:  1999       Impact factor: 2.911

9.  A novel function for transforming growth factor-beta1: upregulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific beta-chymase, mouse mast cell protease-1.

Authors:  H R Miller; S H Wright; P A Knight; E M Thornton
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

10.  Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta.

Authors:  X Yang; J J Letterio; R J Lechleider; L Chen; R Hayman; H Gu; A B Roberts; C Deng
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

View more
  142 in total

Review 1.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

Review 2.  Thrombospondin-1 in ocular surface health and disease.

Authors:  William Foulsham; Thomas H Dohlman; Sharad K Mittal; Yukako Taketani; Rohan Bir Singh; Sharmila Masli; Reza Dana
Journal:  Ocul Surf       Date:  2019-06-05       Impact factor: 5.033

3.  Pathogen-reduced PRP blocks T-cell activation, induces Treg cells, and promotes TGF-β expression by cDCs and monocytes in mice.

Authors:  Johnson Q Tran; Marcus O Muench; Rachael P Jackman
Journal:  Blood Adv       Date:  2020-11-10

4.  Comprehensive analysis of a mouse model of spontaneous uveoretinitis using single-cell RNA sequencing.

Authors:  Jacob S Heng; Sean F Hackett; Genevieve L Stein-O'Brien; Briana L Winer; John Williams; Loyal A Goff; Jeremy Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

Review 5.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

Review 6.  Synergetic roles of TGF-β signaling in tissue engineering.

Authors:  Eun-A Kwak; Nam Y Lee
Journal:  Cytokine       Date:  2019-01-08       Impact factor: 3.861

Review 7.  Immunotherapy for Colorectal Cancer: A Review of Current and Novel Therapeutic Approaches.

Authors:  Aaron J Franke; William Paul Skelton; Jason S Starr; Hiral Parekh; James J Lee; Michael J Overman; Carmen Allegra; Thomas J George
Journal:  J Natl Cancer Inst       Date:  2019-11-01       Impact factor: 13.506

Review 8.  Studying Sjögren's syndrome in mice: What is the best available model?

Authors:  Ghada Abughanam; Ola M Maria; Simon D Tran
Journal:  J Oral Biol Craniofac Res       Date:  2020-12-08

Review 9.  Intracellular and extracellular TGF-β signaling in cancer: some recent topics.

Authors:  Kohei Miyazono; Yoko Katsuno; Daizo Koinuma; Shogo Ehata; Masato Morikawa
Journal:  Front Med       Date:  2018-07-24       Impact factor: 4.592

10.  Cryo-EM Reveals Integrin-Mediated TGF-β Activation without Release from Latent TGF-β.

Authors:  Melody G Campbell; Anthony Cormier; Saburo Ito; Robert I Seed; Andrew J Bondesson; Jianlong Lou; James D Marks; Jody L Baron; Yifan Cheng; Stephen L Nishimura
Journal:  Cell       Date:  2020-01-16       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.